Jiangsu Zenji Pharmaceuticals Ltd. is a national high-tech enterprise focusing on structural invention of drug innovation, research and application of new technologies, and the research and manufacture of characteristic generic drugs.There are two research and development institutes in Nanjing and Suzhou, two production bases in Huai'an and Suzhou, respectively, and a third production base under construction in Rizhao, Shandong. Currently, Zenji has about 900 employees, in which there are around 200 professional scientific research and technical personnel, with more than 30 people with a master's degree, a doctor’s degree or above, including many overseas returnees and foreign employees. The Executives are of medical, pharmaceutical, chemistry, and management professionals. Zenji focuses on the development and manufacture of antiviral, antitumor, cardio-cerebrovascular and digestive drugs. Antiviral drugs include Remdesivir, Favipiravir, Peramivir, Sofosbuvir, Ledipasvir, Velpatasvir, etc.; Antitumor drugs include Eribulin, Alectinib, Palbociclib, etc.; Cardio-cerebrovascular drugs include Colpidogrel Bisulfate, Citicoline sodium, Pitavastatin, etc.; Digestive drugs include Cimetidine, Famotidine, Rebamipide, etc. The company conducts research on innovative drugs through joint and independent development and obtains structural invention patents and technology application patents.
Products & Services
Celecoxib
Cimetidine
Country
People's Republic of ChinaJiangsu Zenji Pharmaceuticals
Country
People's Republic of ChinaCity
Huai An Shi
Address
Chao Hu Lu
Clopidogrel
Clopidogrel Bisulfate
Country
People's Republic of ChinaZenji Pharmaceuticals
Country
People's Republic of ChinaCity
Su Zhou Shi
Address
Xu Guan Jie, 215051
Sites
Zenji Pharmaceuticals
Country
People's Republic of ChinaCity
Su Zhou Shi
Address
Xu Guan Jie, 215051
Zenji Pharmaceuticals (Suzhou) Ltd.
Audited
Country
People's Republic of ChinaCity
Suzhou, Jiangsu
Jiangsu Zenji Pharmaceuticals
Country
People's Republic of ChinaCity
Huai An Shi
Address
Chao Hu Lu